Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Jan 30, 2022 9:33pm
416 Views
Post# 34377115

RE:RE:Ruthenium Complex + NK Cell Immunotherapy

RE:RE:Ruthenium Complex + NK Cell Immunotherapy

Yes, that is correct Eoganacht.  However, much of the excitement for me re: TLT's form of ACT arises not so much from the PDT, but from the metallic compound that makes it all happen.  The fact that this compound has the ability to be cytotoxic/virucidal in the absence of light/irradiation bodes well for the future of this ACT in its many forms (stand-alone, combo, +/- PDT, etc.).  

Imo, it is only a matter of time that traditional PDT will be augmented &/or replaced in many instances (I.e. in the treatment of large or deep-seated solid tumors) by other more versatile forms of compound activation/irradiation.  One example of this that shows significant promise preclinically is in the use of nanoscintillation that does not require the need for external PDT or external irradiation of any kind.  Such an approach also exploits more novel/effective compound delivery platforms that can potentially enhance not only cytotoxicity, but also the immune response.   Time will tell, but it's coming soon imo.  JMO.  Good luck....

<< Previous
Bullboard Posts
Next >>